StageZero Life Sciences Ltd.
OTC: SZLSF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- James R. Howard-Tripp
- Employees
- 40
- Headquarters
- Richmond Hill, Canada
- IPO year
- 2009
- Market cap
- $630.0K
- Website
- https://www.stagezerolifesciences.com
Loading SZLSF…
Loading profile data…Frequently asked questions about SZLSF
What does StageZero Life Sciences Ltd. (SZLSF) do?
StageZero Life Sciences Ltd. is a vertically integrated healthcare enterprise focused on the development and commercialization of proprietary molecular diagnostic tests. These tests are primarily designed for the early detection of diseases and to facilitate personalized health management, with a particular emphasis on oncology-related condition...
Where does SZLSF trade?
StageZero Life Sciences Ltd. (SZLSF) trades on the Other OTC.
What sector is SZLSF in?
StageZero Life Sciences Ltd. (SZLSF) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of StageZero Life Sciences Ltd.?
James R. Howard-Tripp is the chief executive officer of StageZero Life Sciences Ltd. (SZLSF).
Where is StageZero Life Sciences Ltd. headquartered?
StageZero Life Sciences Ltd. is headquartered in Canada.
Does SZLSF pay a dividend?
StageZero Life Sciences Ltd. (SZLSF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did SZLSF go public?
StageZero Life Sciences Ltd. (SZLSF) completed its initial public offering in 2009.